Evidence on Testosterone Therapy Does Not Support Cardiac Risk | ConsultantLive

“A close examination reveals that this study is too flawed to provide meaningful information on the cardiovascular risk of testosterone therapy,” stated Dr Miner. “First, the overall rate of nonfatal MI in the testosterone-treated group increased in all ages from 3.48 to 4.75 per 1,000 person-years. This amounts to just greater than one additional MI in 1,000 years of exposure to testosterone. It is misleading to characterize this increase as ‘substantial’ based on relative risk when the absolute risk is so small and clinically meaningless.”

via Evidence on Testosterone Therapy Does Not Support Cardiac Risk | ConsultantLive.